ElijahJobs Posted - 21 hours ago

$PRTA Is there data readout before December 20? I ask this because I noticed something strange and peculiar with the December options.

Scanners_Free Posted - 1 week ago

$PRTA MISS SALEES

globalmacro Posted - 10/28/24

$PRTA moving…

Estimize Posted - 10/28/24

Here’s what 3 Estimize analysts believe $PRTA will report for Q3 2024 revenue [Reporting 10/31 AMC] http://www.estimize.com/intro/prta?char

justiceforb_85 Posted - 10/27/24

$PRTA when do we anticipate data release for birtamimab in stage IV amyloidosis? Bit skeptical of company due to issues with prasinezumab.

ElijahJobs Posted - 10/22/24

$PRTA Publish some data already, you piece of shit CEO! Get to work or get fired without pay. JMO

globalmacro Posted - 1 month ago

$PRTA buying here

WoldanStanford Posted - 1 month ago

$PRTA drop to 10$ pls ^^ ill buy

ElijahJobs Posted - 1 month ago

$PRTA When $50? When $100? The management blows.

TheLearnerEarner Posted - 1 month ago

$PRTA looking good today 💸

TheLearnerEarner Posted - 1 month ago

$PRTA ✅ UNDERVALUED QUALITY stock swing trade - healthcare - mid cap - 5/9 F-Score - 0.52x relative volume - 1x analyst outperform rating - 5x analysts buy rating - revenue is forecast to grow 31.16% per year - trading at 80.9% below estimate of its fair value - short to medium term gains 📈 RSI: 25.32 (oversold) 📊 Analyst Price Target: $64.00 - $98.70 (287.17% - 485.76% above Price) 🌟 Range (12m) $15.52 - $55.89 💰 NEWSDESK (article idea is for PRTA only) 📰 https://finance.yahoo.com/news/prothena-corporation-plc-ptra-positioning-042827697.html

THE_ORJINAL Posted - 1 month ago

$PRTA Started a position. CMO departure and data controversy way overblown here IMO. Too many value catalysts on the horizon.

gogingergo Posted - 1 month ago

$PRTA $S $SAVA

PhishTourFunds Posted - 1 month ago

$PRTA 👀

barlaw Posted - 1 month ago

$SAVA So how ‘bout this guy Dr. Masilah? Runs Neuroscience at NIA/NIH for many years, in charge of billions of research $s and directing drug development to his areas of interest. He’s now accused of fraud in scores of papers over many years — in the AD/PD spaces, mostly about MABS and alpha synuclein. So Prothena ($PRTA) only gets their feathers ruffled a bit when the Science article comes out 9/27. Their P2 drug is the one most closely spawned from Masilah’s tainted tenure (he was just fired), and it hasn’t even shown much promise. So while Wang’s misdeeds pale in comparison to Masilah’s, the therapeutic candidate Simufilam is brutalized by organized short/distort efforts for years. It’s sure hard to come away with the notion that Simu is destined to be a fail when you compare these two market reactions to research misconduct. But oh, PRTA has a BP sponsor, so it’s apples and oranges. Make no mistake, Simu is seen as a massive threat to the status quo, that being: “BP rules”.

Lingus Posted - 1 month ago

$PRTA Prothena's prasinezumab linked to apparently huge fraud. The real reason for the CMO to leave? Prasinezumab worthless? https://www.science.org/content/article/research-misconduct-finding-neuroscientist-eliezer-masliah-papers-under-suspicion

TheLearnerEarner Posted - 1 month ago

$PRTA looking good today 📋

inphatec1 Posted - 1 month ago

$PRTA Ender

tradingtwenty Posted - 1 month ago

Top 5 oversold stocks that have trended in the past 24 hours: $ADTX 16.53🔥 $SLXN 19.56 $FBRX 23.27 $UAVS 23.61 $PRTA 24.62 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

GambitMentality Posted - 09/30/24

Today’s #StockMarket EOD Biggest Losers by %, led by $HRTG $SDST and $PRTA to lead the TOP 3

Jamesiam Posted - 09/30/24

$PRTA chief medical officer, leaving is a red flag. The data must be awful.

360sage Posted - 09/30/24

$PRTA Starter

Luckiest_Man_Alive Posted - 09/30/24

$PRTA

TheLearnerEarner Posted - 09/30/24

$PRTA ✅ HUGELY UNDERVALUED QUALITY stock swing trade - healthcare - mid cap - 5/9 F-Score - 8x relative volume - 1x analyst outperform rating - 1x analyst overweight rating - 3x analysts buy rating - trading at 76.7% below estimate of its fair value - short to medium term gains 📈 RSI: 23.68 (oversold bullish) 📊🐂 Analyst Price Target: $69.50 - $98.70 (326.38% - 526.07% above Price) 🌟 Range (12m) $18.69 - $55.89 💰 NEWSDESK (last recent article) 📰 https://finance.yahoo.com/news/prothena-participate-upcoming-healthcare-conferences-200500786.html

jeffgosia6 Posted - 09/30/24

$PRTA .

jeffgosia6 Posted - 09/30/24

$PRTA

null_user Posted - 09/30/24

$PRTA not looking good at all

DonCorleone77 Posted - 09/30/24

$PRTA Prothena sinks 20% to $16.11 following exit of Chief Medical Officer

jeffgosia6 Posted - 09/30/24

$PRTA in

inphatec1 Posted - 09/30/24

$PRTA Starter